Revenue Breakdown
Composition ()
No data
Revenue Streams
Integer Holdings Corp (ITGR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Cardiac Rhythm Management & Neuromodulation, accounting for 59.5% of total sales, equivalent to $261.73M. Other significant revenue streams include Advanced Surgical, Orthopedics & Portable Medical and Cardio & Vascular. Understanding this composition is critical for investors evaluating how ITGR navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Integer Holdings Corp maintains a gross margin of 25.16%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.16%, while the net margin is 3.75%. These profitability ratios, combined with a Return on Equity (ROE) of 8.58%, provide a clear picture of how effectively ITGR converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ITGR competes directly with industry leaders such as ICUI and MMED. With a market capitalization of $3.03B, it holds a significant position in the sector. When comparing efficiency, ITGR's gross margin of 25.16% stands against ICUI's 38.89% and MMED's 57.05%. Such benchmarking helps identify whether Integer Holdings Corp is trading at a premium or discount relative to its financial performance.
